Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified supply chains for API intermediates.
Novel Rh(III)-catalyzed C-H activation route for C2-sulfonamido indoles. Optimized process offers significant cost reduction in API manufacturing and simplified purification.
Patent CN115215810B reveals catalyst-free synthesis for high-purity triazoles. Enables cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Novel FeCl3-catalyzed route offers high yields and scalability for drug discovery, reducing costs in pharmaceutical intermediate manufacturing.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for trifluoromethyl triazoles. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN118126005B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction in fine chemical manufacturing with scalable air atmosphere reactions.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate manufacturing.
Novel nickel-catalyzed method for 2-pyrrolidone derivatives offers cost-effective scalable synthesis for pharmaceutical intermediates supply chain optimization and high purity standards.
Patent CN118164892A details a novel palladium-catalyzed route for 3-alkynyl indoles. This method offers significant supply chain reliability and cost reduction advantages for pharmaceutical manufacturing.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel palladium-catalyzed carbonylation for indole-3-carboxamide. Efficient, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN117164506B reveals efficient palladium-catalyzed carbonylation. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112125856A details a Pd-catalyzed carbonylation route for 2-CF3 quinazolinones, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel transition-metal-free synthesis of benzothienopyridines via nitrile cyclization. High atom economy, scalable process for API intermediates.
Patent CN113735778B reveals efficient silver oxide promoted route. Delivers high purity intermediates with scalable cost reduction for global supply chains.